Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedNov 28, 2021
DataAggregated Company Financials
Companies25
  • 7D-0.7%
  • 3M-0.7%
  • 1Y9.2%
  • YTD12.0%

Over the last 7 days, the Pharma industry has remained flat, although notably HUTCHMED (China) gained 18%. As for the the longer term, the industry is up 9.2% over the past 12 months.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 28 Nov 2021UK£225.3bUK£61.7bUK£5.7b30.3x
Tue, 26 Oct 2021UK£230.5bUK£58.2bUK£7.5b26.6x
Thu, 23 Sep 2021UK£226.2bUK£58.4bUK£7.5b28.9x
Sat, 21 Aug 2021UK£232.7bUK£58.1bUK£7.5b27.5x
Sat, 05 Jun 2021UK£190.4bUK£56.2bUK£8.5b26.8x
Tue, 09 Mar 2021UK£166.1bUK£57.2bUK£8.3b33.9x
Mon, 30 Nov 2020UK£186.6bUK£57.9bUK£8.4b41.7x
Thu, 03 Sep 2020UK£198.1bUK£59.5bUK£8.5b44.1x
Sun, 07 Jun 2020UK£209.6bUK£59.1bUK£6.8b22.2x
Sat, 29 Feb 2020UK£178.4bUK£55.7bUK£6.0b16.4x
Tue, 03 Dec 2019UK£196.7bUK£56.4bUK£6.6b18.4x
Fri, 06 Sep 2019UK£108.4bUK£21.8bUK£2.1b31.2x
Mon, 10 Jun 2019UK£163.6bUK£52.0bUK£6.1b33.5x
Sun, 03 Mar 2019UK£162.8bUK£51.7bUK£5.6b20.3x
Wed, 05 Dec 2018UK£169.3bUK£50.1bUK£3.5b37.8x
PE Ratio

37.8x

Total Market Cap: UK£169.3bTotal Earnings: UK£3.5bTotal Revenue: UK£50.1b0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 28.8x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 18% per year over the last three years, and revenues for these companies have grown 7.2% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Pharma industry?

Pharma-0.71%

Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 28.8x. This is likely because analysts are expecting annual earnings growth of 25%, which is higher than its past year's earnings decline of 21% per year.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 25% over the next 5 years. This is better than its past earnings decline of 21% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
HCM HUTCHMED (China)17.7%+UK£685.1m16.2%PS21.8x
SAR Sareum Holdings29.7%+UK£45.5m314.0%PB72x
NFX Nuformix8.6%+UK£739.5k-43.8%PS47.7x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NFX

UK£0.016

Nuformix

7D

8.6%

1Y

-43.8%

INDV

UK£2.29

Indivior

7D

-9.3%

1Y

130.0%

DDDD

UK£0.59

4D pharma

7D

-14.7%

1Y

-40.7%